Skinvisible (SKVI) Equity Ratio (2010 - 2026)

Skinvisible has disclosed Equity Ratio across 17 years of filings, most recently posting 88.18 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 88.18, down 39.11% year-over-year; the trailing twelve-month figure through Mar 2026 was 88.18 (down 39.11% YoY), and the FY2025 annual result was 80.45, down 38.0% from the prior year.
• Equity Ratio came in at 88.18 for Q1 2026 at Skinvisible, down from 80.45 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 18.16 in Q2 2022 to a low of 88.18 in Q1 2026.
• The 5-year median for Equity Ratio is 58.3 (2024), against an average of 53.07.
• Across the five-year window, Equity Ratio climbed 17.91% in 2022 and plunged 136.5% in 2023, its largest moves.
• Skinvisible's Equity Ratio stood at 26.91 in 2022, then plunged by 105.89% to 55.4 in 2023, then decreased by 5.23% to 58.3 in 2024, then sank by 38.0% to 80.45 in 2025, then slipped by 9.6% to 88.18 in 2026.
• The last three Equity Ratio figures came in at 88.18 (Q1 2026), 80.45 (Q4 2025), and 74.87 (Q3 2025), per Business Quant data.